Board Performance · 2024
In this section13 topics
- Prevention of Conflicts of Interest3 items
- Prevention of the Use of Inside Information3 items
- Anti-Corruption4 items
- Whistleblowing3 items
- Selection of Directors & Chief Executives5 items
- Selection of Independent Directors2 items
- Evaluation of Board & Subcommittee Performance2 items
- Subcommittees1 item
- Meeting Attendance & Remuneration2 items
- Supervision of Subsidiaries & Associated Companies4 items
- Board Duty Performance — Overview1 item
- Audit Committee Duty Performance1 item
- Executive Committee Duty Performance1 item
Prevention of Conflicts of Interest
Has the Company Acted to Prevent Conflicts of Interest?
Yes
Operations in the Past Year
The Board of Directors has established a policy prohibiting directors, executives, and employees from using their position within the Company to seek personal benefits for themselves, their family members, or close associates, whether in financial matters or otherwise. They must avoid engaging in transactions that involve themselves, except in cases where it is necessary for the benefit of the Company, and in accordance with the guidelines and regulations set by the Stock Exchange of Thailand.
Additionally, the Company requires directors and senior executives to submit reports on their own interests and those of related parties. This ensures that the Company has the necessary information to comply with regulations regarding related party transactions, preventing conflicts of interest with individuals and entities involved. The Company also requires the reporting of securities holdings by directors and executives to the Board of Directors. Directors and executives must abstain from participating in decisions where they have an interest or conflict of interest, whether direct or indirect.
Number of Conflict-of-Interest Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to conflicts of interest (cases) | 0 | 0 | 0 |
Prevention of the Use of Inside Information
Has the Company Acted to Prevent the Use of Inside Information?
Yes
Operations in the Past Year
The Company has established that directors or executives who engage in securities trading of the Company must notify the company secretary at least one day in advance of the transaction. In addition, there are policies and procedures to monitor and control the actions of directors, executives, employees, and staff regarding the use of confidential and/or insider information that has not been publicly disclosed, to prevent them from disclosing or exploiting such information for personal or third-party benefit, whether directly or indirectly, and regardless of whether they receive any compensation. Furthermore, they are prohibited from trading the Company’s securities using insider information. To prevent the misuse of insider information, the Company has set the following guidelines:
1. The Company will provide training to its directors and executives on the duty to report holdings of securities and derivatives in the Company for themselves, their spouses or cohabitants, and minor children. This also applies to legal entities where the director or executive, their spouse or cohabitant, or minor children hold more than 30% of the voting rights of such legal entities. These reports must be submitted to the Securities and Exchange Commission in accordance with Section 59 and Section 275 of the Securities and Exchange Act B.E. 2535, as well as reports on the acquisition or disposal of the Company's securities according to Section 246 and Section 298 of the same Act.
2. Directors and executives are required to prepare and submit reports on the holdings of securities and derivatives in the Company for themselves, their spouses or cohabitants, and minor children. They must also report holdings in legal entities where they or their family members hold more than 30% of the voting rights. These reports must be submitted to the company secretary within 30 days of their appointment as directors or executives, and whenever there are changes to these holdings. Additionally, the company secretary must summarize the reports on securities holdings and changes to the Board of Directors at each quarterly meeting.
3. Directors, executives, and individuals holding management positions in the accounting or financial sectors (from vice president level and above) who have knowledge of material insider information that may affect the price or value of the Company’s securities must refrain from buying, selling, offering to buy or sell, or encouraging others to trade the Company’s securities during the "Embargo Period." The embargo period lasts one month prior to and until the public release of the Company's quarterly and annual financial results. Directors and executives will be notified in writing to refrain from trading the Company's securities at least one month before the public disclosure of such information, and they should wait at least 24 hours after the information is made public before engaging in any trading activity. They are also prohibited from disclosing this insider information to others. Violations of these regulations will be treated as disciplinary offenses under the Company's internal policies and may result in sanctions ranging from verbal or written warnings, reprimands, to dismissal from employment.
4. Directors, executives, and employees of the Company, as well as former directors, executives, and employees who have resigned, are prohibited from disclosing insider information or Company's confidential information, as well as confidential information related to the Company's business partners, to any external parties, even if the disclosure does not cause harm to the Company, its subsidiaries, or business partners.
5. Directors, executives, and employees of the Company, or former directors, executives, and employees, have an obligation to maintain the confidentiality of the Company’s insider information. They are required to use this information solely for the Company's business purposes and are prohibited from using it for the benefit of other companies in which they hold positions, including those where they are shareholders, directors, or executives.
Number of Inside-Information Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to the use of inside information to seek benefits (cases) | 0 | 0 | 0 |
Anti-Corruption
Has the Company Acted on Anti-Corruption?
Yes
Operations in the Past Year
The Company has established an anti-corruption policy to ensure that directors, executives, and employees at all levels are aware of the importance of conducting business ethically, transparently, and in a manner that is accountable, while preventing corruption in all of the Company's business activities.
Regarding the results of the annual assessment of organizational risk and compliance with the anti-corruption policy for the year 2024, the Company's internal auditor conducted an inspection and evaluation of the Company's internal control system. The audit findings concluded that no instances of corrupt practices or fraudulent behavior. Additionally, the audit review report did not identify any non-compliance with applicable laws and regulations. The findings were reported to the Audit Committee.
The Board of Directors has reviewed the anti-corruption policy and concluded that the policy is appropriate and sufficient for the Company's oversight. The Company has provided comprehensive training to employees on anti-corruption practices. Furthermore, the Company is committed to joining the Thai Private Sector Collective Action Against Corruption (CAC) initiative in the future.
Form of Anti-Corruption Operations
| Operation |
|---|
| Review of appropriateness in anti-corruption |
| Assessment and identification of corruption risk |
| Review of the completeness and adequacy of the process by the Audit Committee or auditor |
Number of Corruption Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to corruption (cases) | 0 | 0 | 0 |
Whistleblowing
Has the Company Implemented Whistleblowing Procedures?
Yes
Operations in the Past Year
The Company has established a Whistleblowing Policy to receive complaints and wrongdoing regarding corruption or non-compliance with laws, regulations, Company rules, and the Company’s code of business ethics. The Company has provided channels for reporting complaints and wrongdoing through mail, email, and telephone. In 2024, there were no complaints or reports of misconduct or corruption. This information has been reported to the Audit Committee and the Board of Directors.
Number of Whistleblowing Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues received through whistleblowing channels (cases) | 0 | 0 | 0 |
Selection of Directors & Chief Executives
Are Directors Selected Through the Nomination Committee?
Yes
Are Chief Executives Selected Through the Nomination Committee?
Yes
Number of Directors from Major Shareholders
2
Rights of Minority Shareholders on Director Appointment
The Board of Directors provides an opportunity for minority shareholders to propose candidates who are suitably qualified to be elected as directors of the Company, in accordance with the criteria, regulations, and procedures set by the Company.
Method of Director Appointment
| Method |
|---|
| Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights |
Selection of Independent Directors
Criteria for Selecting Independent Directors
Qualifications
The Company has defined the meaning of “independent director” in compliance with the Notification of the Capital Market Supervisory Board No. Tor Jor. 39/2559, Re: Application for and Approval of Offering for Sale of Newly Issued Shares, which contains the following criteria:
1. Holding shares not exceeding 1 percent of the total number of shares with voting rights of the Company, its parent company, subsidiary company, associate company, major shareholder or controlling person, including shares held by related persons of such independent director.
2. Neither being nor used to be an executive director, employee, staff, advisor who receives salary, or controlling person of the Company, its parent company, subsidiary company, associate company, same-level subsidiary company, major shareholder or controlling person, unless the foregoing status has ended not less than two years prior to the date of being appointed as independent director. Such prohibited characteristic shall not include the case where the independent director used to be a government official or advisor of a government unit, which is a major shareholder or controlling person of the Company.
3. Not being a person related by blood or legal registration as father, mother, spouse, sibling, and child, including spouse of child of other director, executive, major shareholder, controlling person, or person to be nominated as director, executive or controlling person of the Company or its subsidiary company.
4. Neither having nor used to have a business relationship with the Company, its parent company, subsidiary company, associate company, major shareholder or controlling person, in the manner which may interfere with his/her independent judgement, and neither being nor used to be a significant shareholder or controlling person of any person having a business relationship with the Company, its parent company, subsidiary company, associate company, major shareholder or controlling person, unless the foregoing relationship has ended not less than two years prior to the date of being appointed as independent director.
A business relationship as stated in the first paragraph shall include any normal business transaction, rental or lease of immovable property, transaction relating to assets or services or granting or receipt of financial assistance through receiving or extending loans, guarantee, providing assets as collateral, and any other similar actions, which result in the Company or its counterparty being subject to indebtedness payable to the other party in the amount of three percent or more of the net tangible assets of the Company or twenty million baht or more, whichever is lower. The amount of such indebtedness shall be calculated according to the method for calculation of value of connected transactions under the Notification of the Capital Market Supervisory Board governing rules on connected transactions mutatis mutandis. The consideration of such indebtedness shall include indebtedness occurred during the period of one year prior to the date on which the business relationship with the person commences.
5. Neither being nor used to be an auditor of the Company, its parent company, subsidiary company, associate company, major shareholder or controlling person, and not being a significant shareholder, controlling person, or partner of an audit firm which employs auditors of the Company, its parent company, subsidiary company, associate company, major shareholder or controlling person, unless the foregoing relationship has ended not less than two years prior to the date of being appointed as independent director.
6. Neither being nor used to be a provider of any professional services including those as legal advisor or financial advisor who receives service fees exceeding two million baht per year from the Company, its parent company, subsidiary company, associate company, major shareholder or controlling person, and not being a significant shareholder, controlling person or partner of the provider of professional services, unless the foregoing relationship has ended not less than two years prior to the date of being appointed as independent director.
7. Not being a director appointed as representative of directors of the Company, major shareholder or shareholder who is related to major shareholder.
8. Not undertaking any business in the same nature and in competition to the business of the Company or its subsidiary company or not being a significant partner in partnership or being an executive director, employee, staff, advisor who receives salary or holding shares exceeding 1 percent of the total number of shares with voting rights of other company which undertakes business in the same nature and in competition to the business of the Company or its subsidiary company.
9. Not having any other characteristics, which cause the inability to express independent opinions with regard to the Company’s business operations.
After having been appointed as an independent director, the independent director may be assigned by the Board to take part in the business decisions of the Company, its parent company, subsidiary company, associated company, same-level subsidiary company, major shareholder or controlling person, on condition that these decisions must be collective ones.
In case that the appointed independent director is the person who has or used to have a business relationship, or provision of professional services at a value exceeding the specified amount under item 4 or 6, the Company shall be granted an exemption from such prohibition of having or having had a business relationship or provision of professional services at such excessive value, provided that the Company has obtained an opinion of the Board of Directors indicating that after a consideration in accordance with Section 89/7 of the Securities and Exchange Act, the appointment of such person does not affect the performance of duties and the giving of independent opinions, and that the relevant information is disclosed in the notice of shareholders’ meeting under the agenda of the appointment of an independent director.
To ensure that the composition and operation of the Board of Directors are conducive to the exercise of independent judgment in decision-making, the Company has stipulated in the Board Charter that independent directors shall serve a consecutive term of no more than 9 years from the date of their first appointment as an independent director. In the event that an independent director is to be reappointed, the Board of Directors will reasonably consider the necessity of such reappointment.
Nomination Process
In the nomination and appointment of independent directors, the Nomination and Remuneration Committee will carefully evaluate individuals who meet the qualifications and suitability requirements, with no disqualifications under applicable laws and regulations. The committee will select independent directors from qualified individuals with relevant experience and other appropriate qualifications. The selected candidates will then be presented to the Board of Directors' meeting and/or the shareholders' meeting (as the case may be) for consideration and appointment as directors of the Company.
Did Any Independent Director Have a Business or Professional Relationship?
No
Evaluation of Board & Subcommittee Performance
Criteria for Evaluating Board Performance
The evaluation criteria for the performance of the Board of Directors will assess the overall performance of the Board (as a whole), the performance of sub-committees (by committee), and the individual performance of directors (self-assessment). The evaluation form uses a scoring system ranging from 0 to 4 (where 0 means strongly disagree or no action taken on the issue, and 4 means strongly agree or excellent action taken on the issue). The scores will then be processed into a percentage rate according to the following guidelines:
<60% = Needs Improvement
>60% - 70% = Satisfactory
>70% - 80% = Good
>80% - 90% = Very Good
>90% = Excellent
The evaluation is structured according to the guidelines of the Stock Exchange of Thailand. For the self-assessment of the Board of Directors, the evaluation includes the following 6 main topics:
1. Structure and qualifications of the Board of Directors
2. Roles, duties, and responsibilities of the Board of Directors
3. Board meetings
4. Performance of the directors
5. Relationship with management
6. Directors' self-development
For the self-assessment of sub-committees, the evaluation includes the following 3 main topics:
1. Structure and qualifications of the sub-committee
2. Sub-committee meetings
3. Roles, duties, and responsibilities of the sub-committee
As for evaluation process, after reviewing the evaluation forms to ensure they are complete and accurate, the company secretary will send the evaluation forms to the directors for completion between December and January each year. After the evaluations are collected, the results will be summarized and reported to the board of directors for review.
Evaluation of Board Performance in the Past Year
In 2024, the Company conducted an annual evaluation of the directors' performance according to the established criteria, allowing the directors to review the overall performance of the board and assess the challenges and obstacles faced during the past year. This process is aimed at improving the effectiveness of the board's work in line with good corporate governance practices. The evaluation results for the performance of the board in 2024 were rated as "Excellent".
Subcommittees
Subcommittees
| Results of the Subcommittee's Duty Performance |
|---|
The Company's Nomination and Remuneration Committee comprises two independent directors and one non-executive director. In 2024, the Nomination and Remuneration Committee held two meetings, which all three directors attended. The Nomination and Remuneration Committee has performed its duties in accordance with its charter. The key points are summarized below: 1. Consider the directors who retire by rotation, by proceeding with the recruitment process and criteria set forth to propose to the Board of Directors and the shareholders' meeting for approval. The retiring directors will not participate in the consideration of such matters. In 2024, the Board of Directors provided an opportunity for minority shareholders to propose a list of qualified persons to be elected as directors of the Company to replace the retiring directors in advance. No shareholders submitted a list of any persons to the Company. 2. Consider and refine the policies and criteria for determining the remuneration of directors and the Chief Executive Officer for the year 2024 by considering the responsibilities, size of the business, business environment, and economic conditions, overall performance, and consistency with the Company's strategies and long-term goals. Also, consider and compare with the remuneration rates of companies in the same industry, which are at a competitive and reasonable level. 3. Review the criteria, evaluation process, and performance evaluation form for the committee and the Chief Executive Officer to comply with good corporate governance principles. 4. Conduct an annual performance evaluation to ensure compliance with good corporate governance principles. Based on the 2024 evaluation results, the Nomination and Remuneration Committee has performed effectively and within the scope of duties and responsibilities as defined in the Nomination and Remuneration Committee's charter. 5. Review the Nomination and Remuneration Committee's charter annually to ensure it is up-to-date, appropriate to the scope of duties and responsibilities, and in accordance with the good corporate governance principles. |
The Company's Risk Management Committee comprises two independent directors and one executive director. In 2024, the Risk Management Committee held one meeting, which was attended by all three directors. The Risk Management Committee has performed its duties in accordance with its charter. The key points are summarized below: 1. Consider and endorse the annual risk management plan for 2024, including providing suggestions for improving operations to ensure appropriate and effective implementation, and report significant risk management results to the Board of Directors. 2. Oversee the Company's assessment of the impact and opportunities of identified risks to prioritize risks and enable the Company to have appropriate risk management methods. 3. Conduct an annual performance evaluation to ensure compliance with good corporate governance principles. Based on the 2024 evaluation results, the Risk Management Committee has performed effectively and within the scope of duties and responsibilities as defined in the Risk Management Committee's charter. 4. Review the Risk Management Committee's charter annually to ensure it is up-to-date, appropriate to the scope of duties and responsibilities, and in accordance with the good corporate governance principles. |
The Company's Investment Committee comprises one independent director, one non-executive director, and two executive directors. In 2024, the Investment Committee held two meetings, which all four directors attended. The Investment Committee has performed its duties in accordance with its charter. The key points are summarized below: 1. Refine and review the annual investment policy framework for the Board of Directors' approval. 2. Monitor investment management to comply with the investment policy framework and the Company's objectives. 3. Conduct an annual performance evaluation to ensure compliance with good corporate governance principles. Based on the 2024 evaluation results, the Investment Committee has performed effectively and within the scope of duties and responsibilities as defined in the Investment Committee's charter. 4. Review the Investment Committee's charter annually to ensure it is up-to-date, appropriate to the scope of duties and responsibilities, and in accordance with the good corporate governance principles. |
Meeting Attendance & Remuneration
Types of Remuneration of the Board of Directors
The Company has established a remuneration policy for directors that is appropriate to their duties and responsibilities, comparing remuneration with that of other companies in the same industry. The Nomination and Remuneration Committee is responsible for reviewing and proposing remuneration to the Board of Directors. The committee considers the appropriateness of the policy, including factors such as business expansion and the Company’s profit growth.
In 2024, the Company paid a total of 1,295,000 baht in meeting allowances for the directors. The 2024 Annual General Meeting of Shareholders on April 22, 2024, approved to set the directors' remuneration for the year 2024 as follows:
1. Meeting Allowance
• Board of Directors: Chairman 30,000 baht per meeting, director 20,000 baht per meeting
• Sub-committees (Audit Committee, Nomination and Remuneration Committee, Risk Management Committee,
Investment Committee, Executive Committee): Chairman 25,000 baht per meeting, director 20,000 baht per meeting
2. Other benefits for the Board of Directors include insurance coverage for directors' and officers' liability, as well as expenses for attending training courses organized by the Thai Institute of Directors Association (IOD).
Directors who are executives of the Company and its business group have expressed their intention not to receive directors' remuneration.
Remuneration or Benefits Payable to the Board
| Metric | Amount (Baht) |
|---|---|
| Remunerations or benefits pending payment to the board of directors over the past year (baht) | 0 |
Supervision of Subsidiaries & Associated Companies
Does the Company Have Subsidiaries or Associated Companies?
Yes
Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?
Yes
Mechanism for Overseeing Management of Subsidiaries
The Company has established mechanisms to monitor subsidiaries and/or associated companies both directly and indirectly, including measures to monitor the management of subsidiaries and/or associated companies to protect the Company's investment interests and to control, supervise, manage, and be responsible for the operations of subsidiaries and/or associated companies as if they were a unit of the Company, as follows:
1. The Board of Directors is responsible for monitoring and overseeing the management and operations of subsidiaries and/or associated companies to comply with the policies set by the Company, including laws related to business operations, the Non-Life Insurance Act, and the Notification of the Office of the Insurance Commission (OIC), as well as the Securities and Exchange Act, the notifications of the Capital Market Supervisory Board, and the regulations of the Stock Exchange of Thailand, mutatis mutandis, to the extent not inconsistent with other laws.
2. The Board of Directors is responsible for appointing representatives to be directors and executives in subsidiaries and/or associated companies at least in proportion to the shareholding in the subsidiaries and/or associated companies that operate the core business and have regulations or requirements that make the appointment of such persons subject to the approval of the Board of Directors' meeting. The Board of Directors shall also clearly define the scope of duties and responsibilities of the representatives appointed as directors and executives in such subsidiaries and/or associated companies, and define the scope of duties and responsibilities of the representatives that require the consideration of such directors and executives at the board meetings of the subsidiaries and/or associated companies on important matters to be approved by the Board of Directors' meeting prior to such meetings, unless there are restrictions under other laws or conditions of joint ventures with the government, or other cases as prescribed by the Securities and Exchange Act, the notifications of the Capital Market Supervisory Board, or the regulations of the Stock Exchange of Thailand. The directors and executives of the aforementioned subsidiaries and/or associated companies who are appointed or nominated must be qualified as prescribed by the relevant laws and must not have characteristics that render them untrustworthy, according to the SEC's announcement on the characteristics of directors and executives with a lack of trustworthiness. They must also be included in the list of directors and executives in the company’s securities information system and not be subject to any disqualifications under the regulations of the Office of Insurance Commission (OIC).
3. The Board of Directors is responsible for ensuring that subsidiaries and/or associated companies have internal control systems, risk management systems, and fraud prevention systems in place. The Board of Directors shall also establish measures to monitor the performance of subsidiaries and/or associated companies effectively, consistently, and with sufficient prudence to ensure that the operations of subsidiaries and/or associated companies are in accordance with the Company's plans, budgets, policies, as well as laws and announcements on good corporate governance of listed companies, including announcements, regulations, and relevant rules of the Capital Market Supervisory Board, the Office of the Securities and Exchange Commission, and the Stock Exchange of Thailand, the Non-Life Insurance Act, and the Notification of the Office of the Insurance Commission (OIC) effectively and continuously. In addition, the Board of Directors is also responsible for monitoring and ensuring that the directors and executives of subsidiaries and/or associated companies perform their duties and responsibilities as prescribed by law.
4. The Board of Directors is responsible for overseeing and monitoring the subsidiaries and/or associated companies to disclose important information to the Stock Exchange of Thailand, the Securities and Exchange Commission, and investors in general, such as information on financial position and operating results, connected transactions and transactions that may have conflicts of interest of subsidiaries and/or associated companies, acquisitions or disposals of significant assets, and any other material transactions that are not in the ordinary course of business of the subsidiaries and/or associated companies. The disclosure of such information must be adequate, complete, accurate, and within the timeframe specified by the Company and in accordance with the regulations of the relevant authorities.
5. In the event that a subsidiary enters into a related party transaction with a related person of the subsidiary, or a transaction relating to the acquisition or disposal of assets of the subsidiary in accordance with the criteria prescribed by the notifications of the Capital Market Supervisory Board and/or the notifications of the Stock Exchange of Thailand (as the case may be), the Company and the subsidiary must comply with the criteria and procedures prescribed in such notifications prior to entering into such transactions, mutatis mutandis. The subsidiary must comply with the criteria and procedures prescribed in such notifications in the same manner as if the Company were entering into such transactions itself. In the event that such transactions require the approval of the Board of Directors' meeting and/or the shareholders' meeting of the Company, in accordance with the notifications of the Capital Market Supervisory Board and/or the notifications of the Stock Exchange of Thailand and/or relevant laws, the Company and the subsidiary shall consider the size of the transaction compared to the consolidated financial statements of the Company.
6. For any transaction or action that is material or affects the financial position and operating results of the subsidiary and associated company, which is a matter that must be approved by the Board of Directors or the shareholders' meeting of the Company (as the case may be), the Board of Directors shall have the duty to convene a meeting of the Board of Directors and/or a meeting of the shareholders of the Company (as the case may be) to consider and approve such matter before the subsidiary and associated company convenes a meeting of its board of directors and/or shareholders (as the case may be) to consider and approve such transaction or action. In doing so, the Company shall disclose information and comply with the criteria, conditions, procedures, and methods related to the matter for which approval is requested as prescribed in the Public Limited Companies Act, the Civil and Commercial Code, the Securities and Exchange Act, and other relevant laws, as well as the notifications, regulations, and rules of the Capital Market Supervisory Board, the Securities and Exchange Commission, the Office of the Securities and Exchange Commission, and the Stock Exchange of Thailand, mutatis mutandis (to the extent not inconsistent), completely and accurately.
Oversight Mechanisms
| Mechanism |
|---|
| Sending representatives to act as directors, executives or controlling persons in proportion to shareholdings |
| Defining the scope of powers, duties and responsibilities of directors and executives who represent the company in setting important policies |
| Disclosure of financial information and operating results |
| Transactions between the Company and related persons |
| Other important transactions |
| Acquisition or disposal of assets |
| Internal control system of the subsidiary operating the core business is appropriate and sufficient in the subsidiary operating the core business |
Board Duty Performance — Overview
Board Duty Performance — Overall Description
The Board of Directors has reviewed and approved key issues regarding the direction and policies of the Company's operations, including the business plan and annual budget. The Board of Directors oversees and monitors the management's execution to ensure that operations are carried out in accordance with the established policies, strategies, and business plans effectively.
Audit Committee Duty Performance
Results of the Audit Committee's Duty Performance in the Past Year
The Company's Audit Committee comprises three independent directors with accounting and financial expertise. All members meet the qualifications set by the Securities and Exchange Commission and the Stock Exchange of Thailand. The Audit Committee performs its duties as assigned by the Board of Directors and in accordance with the Audit Committee Charter. In 2024, the Audit Committee held four meetings, which were attended by all three members. The Committee's work is consistent with its charter. The key points are summarized below:
1. Review of financial statements.
The Audit Committee reviews the quarterly and annual financial statements before submitting them to the Board of Directors for consideration. The Committee provides useful advice and comments to ensure that the financial statements are prepared in accordance with legal requirements and generally accepted accounting principles, are reliable and timely, and contain sufficient disclosures for the benefit of users of the financial statements. The Audit Committee also meets with the auditors without management present to independently discuss significant accounting and disclosure issues.
2. Review of the internal control system.
The Audit Committee reviews the adequacy of the internal control system by considering the internal audit plan and receiving internal audit reports to ensure that the internal control system is adequate to prevent or mitigate errors, risks, or fraud. The Audit Committee is of the opinion that the Company's internal control system is appropriate and sufficient for its operations, and no material weaknesses were identified.
3. Review of corporate governance and anti-corruption.
The Audit Committee reviews the adequacy of the Company's key policies and the Audit Committee Charter to ensure that the Company has appropriate and effective corporate governance processes that build stakeholder confidence and are consistent with good corporate governance principles. The Committee also reviews related activities to support and promote anti-corruption in accordance with the Company's anti-corruption policy and measures. In 2024, there were no reports of fraud and corruption complaints received.
4. Review of the Company's disclosures in the event of related party transactions or transactions that may involve conflicts of interest.
The Audit Committee reviews related party transactions or transactions that may involve conflicts of interest to ensure that such transactions are reasonable and justified, based on the principles of accuracy, prudence, and transparency, taking into account the interests of the Company and its stakeholders.
5. Supervise internal audit work.
The Audit Committee reviews and approves the annual internal audit plan and acknowledges the internal auditor's performance at its quarterly meetings. The Committee also monitors the progress of remediation efforts to ensure that management prioritizes and addresses the identified risks in a timely manner.
6. Consider the appointment of the Company's auditor.
The Audit Committee selects the auditor based on the scope of services, auditor independence, and reasonableness of audit fees. The Board of Directors and the Shareholders' Meeting approved the appointment of PricewaterhouseCoopers ABAS Limited as the Company's auditor for 2024. The auditor is on the list of auditors approved by the Securities and Exchange Commission.
7. Evaluate the performance of the Audit Committee.
The Audit Committee conducts an annual self-assessment of its performance to ensure compliance with good corporate governance principles. Based on the 2024 assessment, the Audit Committee has performed effectively and within the scope of duties and responsibilities as stipulated in the Audit Committee Charter.
Executive Committee Duty Performance
Results of the Executive Committee's Duty Performance in the Past Year
The Company's Executive Committee consists of 3 executive directors. In 2024, the Executive Committee held 12 meetings, which all 3 directors attended. The Executive Committee has performed its duties in accordance with its charter. The key points are summarized below:
1. Review and consider the Company's annual goals, policies, business plans, and budgets for submission to the Board of Directors for approval.
2. Monitor the Company's operating results and the progress of the Company's projects.
3. Identify and evaluate new business opportunities for the Company.
4. Conduct an annual performance evaluation to ensure compliance with good corporate governance principles. Based on the 2024 evaluation results, the Executive Committee has performed effectively and within the scope of duties and responsibilities as defined in the Executive Committee's charter.
5. Review the Executive Committee's charter annually to ensure it is up-to-date, appropriate to the scope of duties and responsibilities, and in accordance with good corporate governance principles.

